Psyence Biomedical (Psyence Biomedical) Receivables Turnover : 0.00 (As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Psyence Biomedical's Revenue for the six months ended in Mar. 2023 was $0.00 Mil. Psyence Biomedical's average Accounts Receivable for the six months ended in Mar. 2023 was $0.00 Mil.

Psyence Biomedical Receivables Turnover Historical Data

The historical data trend for Psyence Biomedical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Receivables Turnover Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Receivables Turnover

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Receivables Turnover	-	-	-

Competitive Comparison of Psyence Biomedical's Receivables Turnover

For the Biotechnology subindustry, Psyence Biomedical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Receivables Turnover falls into.

Psyence Biomedical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Psyence Biomedical's Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

	Receivables Turnover (A: Mar. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2023 )	/ (	(Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Psyence Biomedical's Receivables Turnover for the quarter that ended in Mar. 2023 is calculated as

	Receivables Turnover (Q: Mar. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2023 )	/ (	(Accounts Receivable (Q: Mar. 2022 )	+	Accounts Receivable (Q: Mar. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Psyence Biomedical (NAS:PBM) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Psyence Biomedical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024